Navigation Links
EU-funded study underlines importance of Congo Basin for global climate and biodiversity
Date:3/7/2012

With its 1.7 billion square kilometres, an area equivalent to 5 times the size of Germany, the Congo Basin forest is the world's second largest tropical forest. The 'State of the Congo Basin Forests 2010' report launched in Douala, Cameroon, at the Annual meeting of the Congo Basin Forest Partnership (CBFP), provides a comprehensive and detailed assessment of the status of this crucial pool for climate regulation and natural resources. It looks at deforestation patterns, points to trends in sustainable forest management and highlights threats to biodiversity.

The Congo Basin, which spans over six countries (Cameroon, Central African Republic, Congo, Democratic Republic of Congo, Equatorial Guinea and Gabon), contains 25% of the total carbon stored in tropical rainforests worldwide. The report explains the important role the Central African countries can have in future climate conventions and in particular in the negotiations on Reducing Emissions from Deforestation and Forest Degradation (REDD). The low deforestation rates measured here with satellite imagery (0.1% per year for the period 1990-2000 and 0.2% per year for the period 2000-2005) are far below those observed in Latin America and in Southeast Asia and make the Congo Basin a possible role model for other tropical forest regions.

The report also outlines that further efforts are needed to protect the habitat of many animal species. Central African countries have developed a dense network of protected areas and established national plans to reach the target of the Convention on Biological Diversity, i.e.17% of the land under protection. However, the lack of long-term management strategies still represents severe threats to the population of big mammals (elephants, gorillas, chimpanzees, bonobos, and okapis). The industrial poaching of elephants for ivory accounts for 70% of the total illegal trade and has cut in half their population in the Democratic Republic of Congo.

Dom
'/>"/>

Contact: Berta Duane
berta.duane@ec.europa.eu
39-033-278-9743
European Commission Joint Research Centre
Source:Eurekalert

Page: 1 2

Related biology news :

1. Long-term study shows effect of climate change on animal diversity
2. £2 million study to reveal workings of dementia genes
3. New study looks to define evangelicals and how they affect polling
4. CU-Boulder study suggests air quality regulations miss key pollutants
5. Researchers study acoustic communication in deep-sea fish
6. Study reveals homeowner perceptions in fire-prone areas
7. Researchers study how pistachios may improve heart health
8. Study: urban black bears live fast, die young
9. New study indicates link between weight gains during pregnancy and dieting history
10. Study reveals specific gene in adolescent men with delinquent peers
11. Sweat it out: UH study examines ability of sweat patches to monitor bone loss
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/11/2015)... , May 11, 2015  Synaptics Incorporated (NASDAQ: ... interface solutions, today announced the appointment of ... Chief Financial Officer, reporting to Rick Bergman ... current Chief Financial Officer, Kathleen Bayless , ... Mr. Ali brings extensive financial management ...
(Date:5/10/2015)... May 11, 2015 Fingerprint Cards (FPC) ... and FPC1155 from the distributor World Peace Industrial Group (WPI), ... in Asia . Deliveries are planned to ... used by smartphone manufacturers in China . ... communicated revenue guidance of + 1 000 MSEK for 2015.   ...
(Date:5/6/2015)... 6, 2015 LifeBEAM, a developer of bio-sensing ... announced today that they will expand their partnership in ... bio-sensing cycling helmet and the first joint project between ... colors in order to give cyclists more style choices ... LifeBEAM and Lazer announced their plan to release a ...
Breaking Biology News(10 mins):Synaptics Appoints Wajid Ali as Senior Vice President and Chief Financial Officer 2Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 235 Million 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 3
... /PRNewswire-iReach/ -- Picofemto LLC , a biomedical software company ... the deployment of its first product, EEG Decision Support ... Cliniscan TM . (Photo: ... , the innovative web-based software as a service (SaaS) ...
... the two copies of each chromosomecalled sister chromatidsto ensure ... during cell division. In this way, each daughter cell ... cell. Pds5 is a protein associated with cohesins; ... there are two variants of Pds5, Pds5A and Pds5B, ...
... , Oct. 2, 2013 SOFIE BIOSCIENCES, an emerging ... Tomography (PET) probes, scanners and chemistry systems, announced today ... company a grant under the Small Business Innovation Research ... over three years, will be administered by the National ...
Cached Biology News:Picofemto Deploys Cloud-Based Cliniscan EEG Analytics and Clinical Decision Support 2Picofemto Deploys Cloud-Based Cliniscan EEG Analytics and Clinical Decision Support 3CNIO researchers delve into the behavior of cohesins 2SOFIE BIO Receives $1.8M Phase II SBIR Grant 2
(Date:5/21/2015)... ANGELES , May 21, 2015  CytRx ... and development company specializing in oncology, today announced ... clinical trial with aldoxorubicin for the treatment of ... brain cancer.  The open-label, multisite trial is designed ... aldoxorubicin in patients whose tumors have progressed following ...
(Date:5/21/2015)... VANCOUVER , May 21, 2015 /PRNewswire/ - ... a clinical stage regenerative medicine company focused on ... an upcoming poster presentation at the International Society ... treatment for chronic Achilles tendinosis currently in a ... on May 29 th from 5:30 PM ...
(Date:5/20/2015)... SAN FRANCISCO, Calif. , May 20, 2015 ... VCYT ) today presented preliminary data demonstrating the ... distinguish idiopathic pulmonary fibrosis (IPF) from other interstitial ... The findings suggest the classifier,s potential to help ... surgery to resolve ambiguity in IPF diagnosis – ...
(Date:5/20/2015)... , May 19, 2015 Research and Markets ... of the "Global Cell Therapy Market Outlook 2020 ... of cell therapy in tissue and regenerative medicine is ... no other options which could help in the growth ... this segment but they are unable to form new ...
Breaking Biology Technology:CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7RepliCel to Present Unique Autologous Cell Treatment for Achilles Tendinosis at International Society for Cellular Therapy Conference 2RepliCel to Present Unique Autologous Cell Treatment for Achilles Tendinosis at International Society for Cellular Therapy Conference 3Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 2Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 3Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 4Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 5Global Cell Therapy Market Outlook 2015-2020 - 262 Cell Therapies & 13 Marketed Cell Therapies 2Global Cell Therapy Market Outlook 2015-2020 - 262 Cell Therapies & 13 Marketed Cell Therapies 3
... stimulate economy ALEXANDRIA, Va., May 7 Today, the ... proposing level funding for the Carl D. Perkins Career ... The Perkins Act is the primary source of federal ... and real-world careers. The Association for Career and Technical ...
... Rib-X Pharmaceuticals, Inc. ("Rib-X" or the "Company"), ... development of novel antibiotics for the treatment of ... presenting two presentations and two posters at the ... Diseases (ECCMID) taking place in Helsinki, Finland from ...
... -- Delcath Systems, Inc., (Nasdaq: DCTH ) ... Hepatic Perfusion (PHP(TM)) System for the treatment of cancers of ... of the Atlantic Melanoma Center and a Principal Investigator of ... Congress on Melanoma, to be held in Vienna, Austria, May ...
Cached Biology Technology:Obama Budget Level Funds Career Technical Education 2Obama Budget Level Funds Career Technical Education 3Rib-X Pharmaceuticals Announces Presentations at the 19th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) 2Rib-X Pharmaceuticals Announces Presentations at the 19th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) 3Eric D. Whitman, MD to Present on the Delcath PHP System(TM) at the 7th World Congress on Melanoma 2Eric D. Whitman, MD to Present on the Delcath PHP System(TM) at the 7th World Congress on Melanoma 3
Rabbit polyclonal to XPC ( Abpromise for all tested applications). Antigen: Synthetic peptide from N-terminus of Human XPC conjugated to a carrier protein Entrez Gene ID: 7508 Swiss ...
Rabbit polyclonal to NIRF ( Abpromise for all tested applications). Antigen: Synthetic peptide derived from residues 186-235 of human NIRF. Entrez Gene ID: 115426 Swiss Protein ID: Q96PU...
...
...
Biology Products: